Centrum Medyczne Dendryt

Katowice 40-684

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer's Disease, Epilepsies, Partial, NMO Spectrum Disorder (NMOSD), Neuromyelitis Optica (NMO)

Studies at this site

• Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) — Completed
• Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo — Completed
• A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy — Completed